Marker dye in urological procedures
Adult: 40 mg preferably via slow IV inj. May also be given via IM inj.
Indications and Dosage
Parenteral
Marker dye in urological procedures Adult: 40 mg preferably via slow IV inj. May also be given via IM inj.
|
Contraindications
Uncontrolled heart failure, history of allergic reactions, haemodynamic instability.
|
Special Precautions
Patient with heart rate and conduction disorders, hypertension, coronary disorders. Pregnancy and lactation.
|
Adverse Reactions
Significant: Idiosyncratic reactions (e.g. rash, pruritus bronchoconstriction), paradoxical pressor effects.
Cardiac disorders: Bradycardia. Gastrointestinal disorders: Nausea, vomiting. Skin and subcutaneous tissue disorders: Skin discoloration (large doses in children and underweight patients). Vascular disorders: Hypertension. |
IM/IV/Parenteral: C
|
Overdosage
Symptoms: Hypertensive crisis and severe bradycardia. Management: May administer peripheral vasodilators.
|
Lab Interference
May interfere with colorimetric methods of urinalysis.
|
Action
Description: Indigo carmine is a marker dye which retains its blue colour during passage through the body. It is used in the test of renal function.arker
Pharmacokinetics: Excretion: Via urine. Elimination half-life: 4-5 minutes (IV). |
Chemical Structure
![]() Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 2723854, Indigo carmine. https://pubchem.ncbi.nlm.nih.gov/compound/Indigo-carmine. Accessed Sept. 25, 2020. |
Storage
Store between 15-30°C. Protect from light.
|
MIMS Class
|
ATC Classification
V04CH02 - indigo carmine ; Belongs to the class of diagnostic agents used to test for renal function.
|
References
Anon. Indigotindisulfonate Sodium. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 16/07/2020. Anon. Indigotinedisulfonate. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 16/07/2020. Buckingham R (ed). Indigo Carmine. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 16/07/2020. Indigo Carmine 40 mg/5 mL Solution for Injection (SERB S.A.). MHRA. https://products.mhra.gov.uk/. Accessed 16/07/2020. Indigo Carmine Injection, Solution (American Regent, Inc.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 16/07/2020.
|